Full-Time

Scientist I

New Product Development

Confirmed live in the last 24 hours

LGC Group

LGC Group

1,001-5,000 employees

Provides scientific tools for life sciences

No salary listed

Senior

Franklin, MA, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • Knowledge of and ability to assess and understand toxicology-based IVD diagnostic tests and immunoassay systems.
  • Willingness to work in BSL-2 laboratory and DEA regulated areas with personal protective equipment for handling potentially infectious or hazardous material.
  • Experience with stage gate design control processes.
  • Demonstrates strong organizational skills to coordinate multiple projects, meet deadlines, solve problems, focus on priorities, and communicate effectively with collaborators.
  • Ability to work independently and thrive in a fast-paced environment, adaptable to changes in development priorities.
  • Accurate and strong verbal and written communication skills with outstanding attention to detail.
  • Proficient in statistical data analysis and articulating conclusions from data, raising issues with insight into implications based on data.
  • Flexible and able to work effectively in a variety of environments and situations.
  • Individual who actively seeks continuous learning and development.
  • Willingness to accommodate less than 5% travel time if necessary.
Responsibilities
  • Proactively communicates upward and cross-functionally with colleagues to build relationships throughout the organization to clearly articulated goals and priorities.
  • Provide technical support for product development and manufacture of new products including IVD controls, reference materials, and QC panels.
  • Provide support for cross-site new product development.
  • Provide support for investigations and trouble-shooting activities, as needed, for technical manufacturing issues.
  • Development of new product specifications and modification of existing specifications to ensure reliable and repeatable manufacturing. Products must be developed using LGC Clinical Diagnostics design control process to ensure compliance with CE and FDA guidelines.
  • Critically analyses data and communicates conclusions to the team.
  • Supports and assists in technical transfers of products into manufacturing.
Desired Qualifications
  • Bachelor’s degree in Biology, Chemistry, or a related area, with a preference for Immunology.
  • 5+ years of experience in a laboratory environment, product development, or technical operations.
  • Experience working in a BSL-2 laboratory and a DEA regulated laboratory.
  • Proficiency in basic and advanced laboratory techniques (e.g., pipetting, balance use, centrifugation, use of BSC hoods, safety procedures, etc).
  • Experience with manufacturing in a cGMP environment.
  • Familiarity with diagnostic and medical device requirements, including ISO 13485.
  • Experience with toxicology biomarkers is preferred.
  • Familiarity with toxicological test methods, platforms, and data analysis is preferred.

LGC Group is a global leader in the life sciences sector, providing scientific tools and solutions that support advancements in healthcare and pharmaceuticals. The company offers a variety of products, including oligo components, probes, primers, and recombinant viral materials, which are essential for detecting diseases and developing vaccines and therapies for conditions like cancer, heart disease, diabetes, asthma, and infectious diseases such as COVID-19, Ebola, and Zika. LGC's products work by enabling precise scientific analysis and experimentation, particularly in areas like mass spectrometry, immunoassay, and nucleic acid chemistry. What sets LGC apart from its competitors is its strong focus on quality and innovation, which helps ensure that its tools meet the high standards required in the life sciences field. The company's goal is to drive improvements in healthcare outcomes and contribute to a safer world through its scientific contributions.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

1841

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for nucleic acid-based diagnostics boosts LGC's growth potential.
  • AI integration in diagnostics enhances LGC's proficiency testing services.
  • LGC's acquisitions strengthen its position in serology and molecular quality controls.

What critics are saying

  • Integration challenges from DiaMex and Virusys acquisitions may disrupt operations.
  • New CEO Joydeep Goswami might cause strategic shifts affecting business operations.
  • Expansion into smart home projects could divert focus from core life sciences.

What makes LGC Group unique

  • LGC Group offers high-quality scientific tools for healthcare and pharmaceuticals.
  • The company specializes in nucleic acid chemistry and recombinant viral materials.
  • LGC's proficiency testing schemes ensure food safety and critical area monitoring.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Remote Work Options

Company News

GBJPL
Apr 15th, 2025
Ensuring Precision in Analysis: Graham B Jackson Pty Ltd Supply of LGC Certified Reference Materials

Graham B Jackson Pty Ltd (GBJPL), an Australian leader in reference materials, partners with the globally renowned LGC Group to supply high-quality CRMs to laboratories across the country.

Health Technology Insights
Apr 4th, 2025
Laboratory Proficiency Testing Market to Reach $2.1 Billion by 2030

For example, LGC Group introduced a proficiency testing (PT) service in April 2020 that uses nucleic acid amplification testing to identify SARS-CoV-2 (COVID-19).

Investors in Healthcare
Jan 10th, 2025
UK: LGC appoints Joydeep Goswami as president and CEO

UK-based LGC, an international life sciences measurement and tools company, has appointed Joydeep Goswami as president and CEO, succeeding Euan O'Sullivan, who decided to step down from his role in early 2024 after fourteen years of service.

LGC Group
Dec 4th, 2024
LGC acquires DiaMex to drive innovation and choice for core laboratory customers

London, UK – 4 December 2024 – LGC today announces an addition to its growing global clinical diagnostics and genomics portfolio, following the acquisition of DiaMex, a manufacturer of third-party serology and molecular quality controls used in clinical laboratories and blood banks across the world.

LGC Group
Dec 4th, 2024
LGC acquires DiaMex to drive innovation and choice for core laboratory customers: Acquisition complements LGC's serology and molecular quality control portfolio and enhances choice of products from a single supplier

LGC acquires DiaMex to drive innovation and choice for core laboratory customers: acquisition complements LGC's serology and molecular quality control portfolio and enhances choice of products from a single supplier.